To test whether AKT functions as a mediator of GC resistance in IKZF1-deficient BCP-ALL cells, we treated control and IKZF1-/- cells with increasing concentrations of prednisolone in the presence or absence of AKT inhibitor MK2206 (21). The gene discussed is AKT1; the disease is acute lymphoblastic leukemia.